Horizon Therapeutics Plc
HZNP
Market Cap$26.6B
Close$
$275.01
136.5% upside
Current Fair Value
136.5% upsideUndervalued by 136.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.60 Billion |
|---|---|
| Enterprise Value | $26.70 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.28 |
| Beta | 1.01 |
| Outstanding Shares | 228,743,143 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 51.1 |
|---|---|
| PEG | 47.14 |
| Price to Sales | 7.75 |
| Price to Book Ratio | 5.06 |
| Enterprise Value to Revenue | 7.33 |
| Enterprise Value to EBIT | 49.94 |
| Enterprise Value to Net Income | 60 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data